Ilsung Is Co., Ltd. (KRX:003120)
South Korea · Delayed Price · Currency is KRW 22,850
+50 (0.22%)
At close: Apr 2, 2026
Ilsung Is Market Cap
Ilsung Is has a market cap or net worth of 159.24 billion as of April 2, 2026. Its market cap has increased by 49.35% in one year.
Market Cap
159.24B
Enterprise Value
-66.55B
Revenue
64.29B
Ranking
n/a
PE Ratio
136.59
Stock Price
22,850.00
Market Cap Chart
Since May 22, 1998, Ilsung Is's market cap has increased from 17.63B to 159.24B, an increase of 803.48%. That is a compound annual growth rate of 8.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 159.24B | 4.82% |
| Dec 30, 2025 | 151.92B | 40.65% |
| Dec 30, 2024 | 108.02B | -34.46% |
| Dec 28, 2023 | 164.82B | 31.69% |
| Dec 29, 2022 | 125.15B | 26.20% |
| Dec 30, 2021 | 99.17B | -10.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AptaBio Therapeutics | 204.24B |
| Kyongbo Pharmaceutical | 200.82B |
| Jeil Pharmaceutical Co.,Ltd | 199.34B |
| Whan In Pharm | 192.60B |
| REYON Pharmaceutical | 184.51B |
| SAMSUNG PHARM. Co., LTD. | 178.36B |
| Daihan Pharmaceutical | 168.76B |
| Hana Pharm | 165.29B |